GTLOX
Price
$20.71
Change
+$0.15 (+0.73%)
Updated
Jul 3 closing price
Net Assets
476.29M
RWMEX
Price
$64.06
Change
+$0.53 (+0.83%)
Updated
Jul 3 closing price
Net Assets
202.05B
Interact to see
Advertisement

GTLOX vs RWMEX

Header iconGTLOX vs RWMEX Comparison
Open Charts GTLOX vs RWMEXBanner chart's image
Glenmede Disciplined US Eq Ptf
Price$20.71
Change+$0.15 (+0.73%)
VolumeN/A
Net Assets476.29M
American Funds Washington Mutual R4
Price$64.06
Change+$0.53 (+0.83%)
VolumeN/A
Net Assets202.05B
GTLOX vs RWMEX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
GTLOX vs. RWMEX commentary
Jul 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GTLOX is a Buy and RWMEX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RWMEX has more cash in the bank: 202B vs. GTLOX (476M). RWMEX pays higher dividends than GTLOX: RWMEX (1.21) vs GTLOX (0.80). GTLOX was incepted earlier than RWMEX: GTLOX (21 years) vs RWMEX (23 years). GTLOX (0.86) is less costly to investors than RWMEX (0.61). GTLOX is a more actively managed with annual turnover of: 61.00 vs. RWMEX (31.00). GTLOX has a lower initial minimum investment than RWMEX: GTLOX (0) vs RWMEX (250). RWMEX annual gain was more profitable for investors over the last year : 7.50 vs. GTLOX (-10.30). RWMEX return over 5 years is better than : 54.85 vs. GTLOX (-11.17).
GTLOXRWMEXGTLOX / RWMEX
Total Expense Ratio0.860.61141%
Annual Report Gross Expense Ratio0.860.61141%
Fund Existence21 years23 years-
Gain YTD2.1165.54438%
Front LoadN/AN/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets476M202B0%
Annual Yield % from dividends0.801.2166%
Returns for 1 year-10.307.50-137%
Returns for 3 years-13.0631.03-42%
Returns for 5 years-11.1754.85-20%
Returns for 10 years2.9068.674%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
OTLK1.780.07
+4.09%
Outlook Therapeutics
NEO7.550.15
+2.03%
NeoGenomics
GLRE14.320.17
+1.20%
Greenlight Capital Re Ltd
RGEN127.470.51
+0.40%
Repligen Corp
ALZN2.94-0.06
-2.00%
Alzamend Neuro Inc.